A Study to Evaluate the Efficacy of UP165 on Sleep Quality and Mood State in Healthy Adults

NCT05821049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2024-04-15

No results posted yet for this study

Summary

A randomized, double blind, placebo controlled, parallel group study to evaluate the efficacy of UP165 on sleep quality and mood state in healthy adults

Conditions

  • Sleep Disturbance

Interventions

OTHER

UPI65 (Low Dose)

Red colored Capsules

OTHER

UP165 (High Dose)

Red colored Capsules

OTHER

Placebo

Red colored Capsules

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2023-12-08
Completion
2023-12-08

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821049 on ClinicalTrials.gov